Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-inferiority Phase IV Trial of SII-Measles-Mumps-Rubella Vaccine vs Priorix in Healthy Infants
TCTR20231108008Phase 4Unknown
- Sponsor
- Masu
- Start
- Jan 2024
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of M-M-R II in measles, mumps, rubella, sponsored by Masu. Status: unknown.
02
Drugs
M-M-R II
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on TCTR20231108008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231108008.